Literature DB >> 10682317

Fukuyama-type congenital muscular dystrophy: the first human disease to be caused by an ancient retrotransposal integration.

T Toda1, K Kobayashi.   

Abstract

Fukuyama-type congenital muscular dystrophy (FCMD), one of the most common autosomal recessive disorders in the Japanese population, is characterized by congenital muscular dystrophy in combination with cortical dysgenesis (micropolygyria). Recently we identified on chromosome 9q31 the gene responsible for FCMD, which encodes a novel 461 amino acid protein that we have termed fukutin. Most FCMD-bearing chromosomes (87%) derive from a single ancestral founder, whose mutation consisted of a 3-kb retrotransposal insertion in the 3' noncoding region of the fukutin gene. Two independent point mutations causing premature termination confirmed that that this gene is responsible for FCMD. FCMD is the first human disease to be caused by an ancient retrotransposal integration. Fukutin contains an amino-terminal signal sequence, which together with results from transfection experiments suggests that it is an extracellular protein. Discovery of the FCMD gene represents an important step toward greater understanding of the pathogenesis of muscular dystrophies and also of normal brain development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10682317     DOI: 10.1007/s001099900065

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  2 in total

1.  Muscular dystrophy: A hidden ancestral legacy trumped.

Authors:  Masayuki Nakamori; Charles Thornton
Journal:  Nature       Date:  2011-10-05       Impact factor: 49.962

2.  Age and origin of the FCMD 3'-untranslated-region retrotransposal insertion mutation causing Fukuyama-type congenital muscular dystrophy in the Japanese population.

Authors:  R Colombo; A A Bignamini; A Carobene; J Sasaki; M Tachikawa; K Kobayashi; T Toda
Journal:  Hum Genet       Date:  2000-12       Impact factor: 4.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.